The Effects of Cannabinoid Agonist, Heat Shock Protein 90 and Nitric Oxide Synthase Inhibitors on Increasing IL-13 and IL-31 Levels in Chronic Pruritus

References

• An S, Zong G, Wang Z, Shi J, Du H, Hu J. 2016. Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea. Neurogastroenterol Motil. 28(7):1083–93.
   PubMedGoogle Scholar
• Atakan Z. 2012. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2(6):241–54.
   PubMedGoogle Scholar
• Avila C, Massick S, Kaffenberger BH, Kwatra SG, Bechtel M. 2020. Cannabinoids for the treatment of chronic pruritus: a review. J Am Acad Dermatol. 82(5):1205–12.
   PubMedGoogle Scholar
• Cevikbas F, Wang X, Akiyama T, Kempkes C, Savinko T, Antal A, Kukova G, Buhl T, Ikoma A, Buddenkotte J, et al. 2014. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 133(2):448–60.
   PubMed Web of Science ®Google Scholar
• Cevikbas F, Lerner EA. 2020. Physiology and pathophysiology of itch. Physiol Rev. 100(3):945–82.
   PubMedGoogle Scholar
• Coleman JW. 2001. Nitric oxide in immunity and inflammation. Int Immunopharmacol. 1(8):1397–406.
   PubMed Web of Science ®Google Scholar
• Crowe AR, Yue W. 2019. Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio Protoc. 9(24). doi:10.21769/BioProtoc.3465
   Web of Science ®Google Scholar
• Elias PM, Wakefield JS. 2011. Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Clin Rev Allergy Immunol. 41(3):282–95.
   PubMedGoogle Scholar
• Esplugues JV. 2002. NO as a signalling molecule in the nervous system. Br J Pharmacol. 135(5):1079–95.
   PubMed Web of Science ®Google Scholar
• Feld M, Garcia R, Buddenkotte J, Katayama S, Lewis K, Muirhead G, Hevezi P, Plesser K, Schrumpf H, Krjutskov K, et al. 2016. The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves. J Allergy Clin Immunol. 138(2):500–8.e24.
   PubMed Web of Science ®Google Scholar
• Garcovich S, Maurelli M, Gisondi P, Peris K, Yosipovitch G, Girolomoni G. 2021. Pruritus as a distinctive feature of type 2 inflammation. Vaccines (Basel). 9(3):303.
   PubMedGoogle Scholar
• Haddadi NS, Shakiba S, Afshari K, Haj-Mirzaian A, Vesaghati S, Gharagozlou S, Foroumadi R, Shafaroodi H, Ostadhadi S, Dehpour AR. 2020. Possible involvement of nitric oxide in the antipruritic effect of metformin on chloroquine-induced scratching in mice. Dermatology. 236(2):151–59.
   PubMed Web of Science ®Google Scholar
• Haruna T, Soga M, Morioka Y, Hikita I, Imura K, Furue Y, Yamamoto M, Imura C, Ikeda M, Yamauchi A, et al. 2015. S-777469, a novel cannabinoid type 2 receptor agonist, suppresses itch-associated scratching behavior in rodents through inhibition of itch signal transmission. Pharmacology. 95(1–2):95–103.
   PubMedGoogle Scholar
• Lee HG, Stull C, Yosipovitch G. 2017. Psychiatric disorders and pruritus. Clin Dermatol. 35(3):273–80.
   PubMedGoogle Scholar
• Linde LD, Ogryzlo CM, Choles CM, Cairns BE, Kramer JLK. 2022. Efficacy of topical cannabinoids in the management of pain: a systematic review and meta-analysis of animal studies. Reg Anesth Pain Med. 47(3):183–91.
   PubMedGoogle Scholar
• Maghfour J, Rietcheck HR, Rundle CW, Runion TM, Jafri ZA, Dercon S, Lio P, Fernandez J, Fujita M, Dellavalle RP, et al. 2020. An observational study of the application of a topical cannabinoid gel on sensitive dry skin. J Drugs Dermatol. 19(12):1204–08.
   PubMedGoogle Scholar
• Matsunaga MC, Yamauchi PS. 2016. IL-4 and IL-13 inhibition in atopic dermatitis. J Drugs Dermatol. 15(8):925–29.
   PubMed Web of Science ®Google Scholar
• Mollanazar NK, Smith PK, Yosipovitch G. 2016. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol. 51(3):263–92.
   PubMed Web of Science ®Google Scholar
• Nakashima C, Yanagihara S, Otsuka A. 2022. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol Int. 71(1):40–46.
   PubMed Web of Science ®Google Scholar
• Nickles MA, Lio PA. 2020. Cannabinoids in dermatology: hope or hype? Cannabis Cannabinoid Res. 5(4):279–82.
   PubMedGoogle Scholar
• Olek-Hrab K, Hrab M, Szyfter-Harris J, Adamski Z. 2016. Pruritus in selected dermatoses. Eur Rev Med Pharmacol Sci. 20(17):3628–41.
   PubMedGoogle Scholar
• Ostadhadi S, Haj-Mirzaian A, Azimi E, Mansouri P, Dehpour AR. 2015. Involvement of nitric oxide in serotonin-induced scratching in mice. Clin Exp Dermatol. 40(6):647–52.
   PubMedGoogle Scholar
• Pockley AG. 2003. Heat shock proteins as regulators of the immune response. Lancet. 362(9382):469–76.
   PubMed Web of Science ®Google Scholar
• Rook AH, Rook KA, Lewis DJ. 2021. Interleukin-31, a potent pruritus-inducing cytokine and its role in inflammatory disease and in the tumor microenvironment. Adv Exp Med Biol. 1290:111–27.
   PubMedGoogle Scholar
• Schopf FH, Biebl MM, Buchner J. 2017. The HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 18(6):345–60.
   PubMed Web of Science ®Google Scholar
• Sheriff T, Lin MJ, Dubin D, Khorasani H. 2020. The potential role of cannabinoids in dermatology. J Dermatolog Treat. 31(8):839–45.
   PubMed Web of Science ®Google Scholar
• Silverberg JI, Pinter A, Alavi A, Lynde C, Bouaziz JD, Wollenberg A, Murrell DF, Alpizar S, Laquer V, Chaouche K, et al. 2021. Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study. J Eur Acad Dermatol Venereol. 35(7):1562–68.
   PubMedGoogle Scholar
• Su Küçük Ö, Güneş B, Taşlidere N, Işik BG, Akaslan T, Özgen FP, Bahali AG. 2022. Evaluation of adult patients with atopic dermatitis treated with dupilumab: a single-center real-life experience. J Cosmet Dermatol. doi:10.1111/jocd.14785
   PubMedGoogle Scholar
• Szyller J, Bil-Lula I. 2021. Heat shock proteins in oxidative stress and ischemia/reperfusion injury and benefits from physical exercises: a review to the current knowledge. Oxid Med Cell Longev. 2021:6678457.
   PubMed Web of Science ®Google Scholar
• Tahamtan A, Tavakoli-Yaraki M, Shadab A, Rezaei F, Marashi SM, Shokri F, Mokhatri-Azad T, Salimi V. 2018. The role of cannabinoid receptor 1 in the immunopathology of respiratory syncytial virus. Viral Immunol. 31(4):292–98.
   PubMed Web of Science ®Google Scholar
• Todurga ZG, Gunduz O, Karadag CH, Ulugol A. 2016. Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids. Acta Neuropsychiatr. 28(6):321–26.
   PubMedGoogle Scholar
• Todurga Seven ZG, Tombulturk FK, Gokdemir S, Ozyazgan S. 2021. the effects of the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin, cannabinoid agonist WIN 55,212-2, and nitric oxide synthase inhibitor Nω-Nitro-L-arginine methyl ester hydrochloride on the serotonin and dry skin-induced itch. Int Arch Allergy Immunol. 183(4):443–452.
   PubMedGoogle Scholar
• Tripathi P, Tripathi P, Kashyap L, Singh V. 2007. The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol. 51(3):443–52.
   PubMed Web of Science ®Google Scholar
• Tukaj S, Węgrzyn G. 2016. Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies. Cell Stress Chaperones. 21(2):213–18.
   PubMedGoogle Scholar
• Tukaj S, Mantej J, Sitko K, Bednarek M, Zillikens D, Ludwig RJ, Bieber K, Kasperkiewicz M. 2021. Evidence for a role of extracellular heat shock protein 70 in epidermolysis bullosa acquisita. Exp Dermatol. 31(4):528–534.
   PubMedGoogle Scholar
• Ulugöl A. 2014. The endocannabinoid system as a potential therapeutic target for pain modulation. Balkan Med J. 31(2):115–20.
   PubMed Web of Science ®Google Scholar
• van Eden W, van der Zee R, Prakken B. 2005. Heat-Shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol. 5(4):318–30.
   PubMed Web of Science ®Google Scholar
• Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, et al. 2017. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. Oncotarget. 8(16):26169–84.
   PubMedGoogle Scholar
• Xiang X, Tu C, Li Q, Wang W, Huang X, Zhao Z, Xiong H, Mei Z. 2020. Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes. Toxicol Appl Pharmacol. 405:115209.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen S, Zhang L, Chen G, Chen J. 2021. The anti-inflammatory and anti-pruritus mechanisms of huanglian jiedu decoction in the treatment of atopic dermatitis. Front Pharmacol. 12:735295.
   PubMed Web of Science ®Google Scholar
• Ye C, Huang C, Zou M, Hu Y, Luo L, Wei Y, Wan X, Zhao H, Li W, Cai S, et al. 2019. The role of secreted Hsp90α in HDM-induced asthmatic airway epithelial barrier dysfunction. BMC Pulm Med. 19(1):218.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Bernhard JD. 2013. Clinical practice. Chronic pruritus. N Engl J Med. 368(17):1625–34.
   PubMed Web of Science ®Google Scholar
• Zininga T, Ramatsui L, Shonhai A. 2018. Heat shock proteins as immunomodulants. Molecules. 23(11):2846.
   PubMed Web of Science ®Google Scholar